Cost-Effectiveness of Dabigatran vs. Rivaroxaban and Vitamin K Antagonists in Elderly Patients with Nonvalvular Atrial Fibrillation in Spain
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1752
https://www.valueinhealthjournal.com/article/S1098-3015(16)33118-7/fulltext
Title :
Cost-Effectiveness of Dabigatran vs. Rivaroxaban and Vitamin K Antagonists in Elderly Patients with Nonvalvular Atrial Fibrillation in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33118-7&doi=10.1016/j.jval.2016.09.1752
First page :
A651
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1653